FNP 120
Alternative Names: FNP-120Latest Information Update: 08 Jun 2022
At a glance
- Originator Ferrer
- Class Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Diabetic retinopathy
Most Recent Events
- 05 May 2022 Phase-I clinical trials in Diabetic retinopathy in Spain (unspecified route) (Ferrer pipeline, May 2022)